Best TWAS P=7.64e-14 · Best GWAS P=1.51e-13 conditioned to 0.0982
# | Study | Tissue | Gene | h2 | eQTL R2 | model | # weights | model R2 | model R2 P | eQTL GWAS Z | TWAS Z | TWAS P | Top SNP corr | PP3 | PP4 | joint |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | GTEx | Artery Tibial | AKR1C2 | 0.14 | 0.10 | enet | 10 | 0.15 | 1.2e-11 | -7.2 | -6.5 | 9.3e-11 | 0.94 | 0.00 | 1.00 | FALSE |
2 | GTEx | Brain Cerebellar Hemisphere | AKR1C1 | 0.46 | 0.14 | lasso | 4 | 0.23 | 1.4e-06 | -3.6 | 6.3 | 3.2e-10 | -0.85 | 0.01 | 0.96 | FALSE |
3 | GTEx | Brain Cortex | AKR1C2 | 0.49 | 0.10 | lasso | 11 | 0.26 | 1.1e-07 | -7.4 | -6.1 | 9.9e-10 | 0.85 | 0.01 | 0.98 | FALSE |
4 | GTEx | Cells Transformed fibroblasts | AKR1C2 | 0.28 | 0.23 | lasso | 6 | 0.21 | 1.9e-15 | -7.4 | -7.4 | 1.2e-13 | 1.00 | 0.00 | 1.00 | FALSE |
5 | GTEx | Esophagus Muscularis | AKR1C2 | 0.30 | 0.21 | lasso | 2 | 0.19 | 8.5e-12 | -7.4 | -7.4 | 1.2e-13 | 1.00 | 0.00 | 1.00 | FALSE |
6 | GTEx | Heart Atrial Appendage | AKR1C2 | 0.28 | 0.37 | lasso | 3 | 0.29 | 1.2e-13 | -7.2 | -7.2 | 4.1e-13 | 0.98 | 0.00 | 1.00 | FALSE |
7 | GTEx | Ovary | AKR1C3 | 0.35 | 0.20 | lasso | 9 | 0.22 | 3.9e-06 | -7.4 | -6.3 | 2.2e-10 | 0.91 | 0.01 | 0.97 | FALSE |
8 | GTEx | Skin Sun Exposed Lower leg | AKR1C2 | 0.17 | 0.18 | lasso | 2 | 0.18 | 4.0e-15 | -7.3 | -7.4 | 1.8e-13 | 1.00 | 0.00 | 1.00 | FALSE |
9 | GTEx | Testis | AKR1C2 | 0.44 | 0.36 | lasso | 4 | 0.36 | 8.5e-17 | -7.4 | -7.1 | 9.7e-13 | 1.00 | 0.00 | 1.00 | FALSE |
10 | ROSMAP | Brain Pre-frontal Cortex | AKR1C2 | 0.56 | 0.40 | enet | 28 | 0.46 | 1.0e-65 | -7.4 | -7.3 | 3.6e-13 | 0.93 | 0.00 | 1.00 | FALSE |
11 | The Cancer Genome Atlas | Kidney Renal Clear Cell Carcinoma | AKR1C1 | 0.07 | 0.04 | enet | 10 | 0.02 | 1.0e-03 | -7.2 | 7.5 | 7.6e-14 | -0.88 | 0.00 | 0.99 | TRUE |
12 | The Cancer Genome Atlas | Kidney Renal Clear Cell Carcinoma | AKR1C2 | 0.12 | 0.11 | lasso | 6 | 0.09 | 1.6e-10 | -7.4 | -7.4 | 1.8e-13 | 1.00 | 0.00 | 1.00 | FALSE |
13 | The Cancer Genome Atlas | Kidney Renal Papillary Cell Carcinoma | AKR1C2 | 0.29 | 0.21 | lasso | 1 | 0.21 | 4.7e-12 | -7.2 | -7.2 | 4.3e-13 | 0.98 | 0.00 | 1.00 | FALSE |
14 | The Cancer Genome Atlas | Brain Lower Grade Glioma | AKR1C2 | 0.09 | 0.05 | blup | 62 | 0.05 | 3.4e-06 | -7.2 | -5.9 | 4.5e-09 | 0.89 | 0.00 | 1.00 | FALSE |
15 | The Cancer Genome Atlas | Prostate Adenocarcinoma | AKR1C2 | 0.39 | 0.18 | enet | 14 | 0.23 | 2.5e-23 | -7.4 | -7.0 | 1.9e-12 | 0.85 | 0.00 | 1.00 | FALSE |
16 | The Cancer Genome Atlas | Soft Tissue Sarcoma | AKR1C2 | 0.07 | 0.04 | enet | 5 | 0.06 | 1.1e-04 | -3.6 | -5.3 | 1.4e-07 | 0.74 | 0.01 | 0.81 | FALSE |
17 | The Cancer Genome Atlas | Thyroid Carcinoma | AKR1C2 | 0.09 | 0.08 | lasso | 3 | 0.08 | 7.2e-08 | -7.2 | -6.9 | 5.3e-12 | 0.90 | 0.00 | 1.00 | FALSE |